Introduction
Gouty panniculitis is an unusual dermatologic manifestation of gout. The patient may present with subcutaneous nodules or indurated plaques, which may precede or appear subsequently to the joints involvement of chronic tophaceous gout.
Pathogenesis of gouty panniculitis is not fully understood but it has been postulated that overproduction and accumulation of uric acid are triggered by preexisting subcutaneous tissue damage with concomitant localized inflammation [1] . We report a case of gouty panniculitis presenting as extensive subcutaneous involvement with no significant history of gout.
Case report
A 40-year-old man presented with a 2-year history of widespread nontender, firm, and white to yellow nodules and plaques over the trunk, arms, legs, and dorsum of both feet. The 
Discussion
Gouty panniculitis has been described as a rare cutaneous manifestation of gout characterized by the presence of monosodium urate crystal deposition in the subcutaneous tissue with predominantly lobular inflammation [1] . While an association with elevated serum uric acid levels is evident, our current knowledge of the pathogenesis is incomplete [1, 2] . Pre-existing tissue damage induced by venous stasis [7] . We believe the presentation of our patient, both clinical and histopathological, is similar to the previously proposed term "gout nodulosis" [8] . Obesity, chronic venous insufficiency, long-term use of furosemide and glucocorticoids are considered to be the risk factors for cutaneous deposit of uric acid [4, 5] . Therefore, obesity was considered to be the possible risk factor for the development of gouty panniculitis in our case.
There is no specific therapy for gouty panniculitis. Some reports noted improvement of skin lesions following systemic treatment for hyperuricemia. High-dose allopurinol 600-1,200 mg/day and colchicine have been reported to improve the lesions of gouty panniculitis and prevent formation of new lesions [3] . Our patient was treated with allopurinol 600 mg/day, which resulted in the gradual improvement of skin lesions over 3 months period. Serum uric acid level decreased to 8.4 mg/dL over 6 months period and there were no episodes of arthritis or arthralgia at the latest follow-up visit.
Conclusion
Disseminated gouty panniculitis is an extremely unusual presentation of cutaneous tophi and may not be apparent to the physician in early stages of its development. Clinical suspicion should be taken in patients with known history of gout or long-standing hyperuricemia with the onset of new cutaneous lesions as described.
